Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone

International Journal of Antimicrobial Agents

Volumn 37, Issue 4, 2011, Pages 380-384

  Cateau, Estelle ^a   Berjeaud, Jean Marc ^a   Imbert, Christine ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

Biofilm; Candida; Echinocandin; Lock solution; Posaconazole

Indexed keywords

CASPOFUNGIN; ECHINOCANDIN; MICAFUNGIN; POSACONAZOLE; PYRROLE; SILICONE;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; CATHETER INFECTION; CONTROLLED STUDY; FUNGAL METABOLISM; FUNGAL STRAIN; IN VITRO STUDY; INFECTION CONTROL; MICROBIAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AZOLES; BIOFILMS; CANDIDA; ECHINOCANDINS; SPECIES SPECIFICITY;

EID: 79952814047     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.12.016     Document Type: Article

References (15)

1. Hawser SP, Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 1995;39:2128-31.
2. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Anti-fungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002;46:1773-80. (Pubitemid 34535196)
3. Pappas PG, Kauffman CA, Andes D, Benjamin DKJJr, Calandra TF, Edwards JE Jr., et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-35.
4. Carratala J. The antibiotic-lock technique for therapy of 'highly needed' infected catheters. Clin Microbiol Infect 2002;8:282-9.
5. Lepape A. Is there any microbiologically based specificity of the management of catheter related infections? [in French]. Ann Fr Anesth Reanim 2005;24:298-301.
6. Angel-Moreno A, Boronat M, Bolanos M, Carrillo A, Gonzalez S, Perez Arellano JL. Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review. J Infect 2005;51:85-7.
7. Viale P, Petrosillo N, Signorini L, Puoti M, Carosi G. Should lock therapy always be avoided for central venous catheter-associated fungal bloodstream infections? Clin Infect Dis 2001;33:9-51, 1947-8; author reply.
8. Seidler M, Salvenmoser S, Muller FM. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections. Int J Antimicrob Agents 2006;28:568-73.
9. Katragkou A, Chatzimoschou A, Simitsopoulou M, Dalakiouridou M, Diza-Mataftsi E, Tsantali C, et al. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob Agents Chemother 2008;52:357-60.
10. Cateau E, Rodier MH, Imbert C. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth. J Antimicrob Chemother 2008;62:153-5.
11. Tobudic S, Lassnigg A, Kratzer C, Graninger W, Presterl E. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases. Mycoses 2010;53:208-14.
12. Hawser SP, Islam K. Binding of Candida albicans to immobilized amino acids and bovine serum albumin. Infect Immun 1998;66:140-4. (Pubitemid 28018812)
13. Melo AS, Colombo AL, Arthington-Skaggs BA. Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob Agents Chemother 2007;51:3081-8. (Pubitemid 350067512)
14. Shuford JA, Rouse MS, Piper KE, Steckelberg JM, Patel R. Evaluation of caspo-fungin and amphotericinB deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J Infect Dis 2006;194:710-3. (Pubitemid 44297859)
15. Pfaller MA, Messer SA, Boyken L, Hollis RJ, Rice C, Tendolkar S, et al. In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagn Microbiol Infect Dis 2004;48:201-5.